BLPH NASDAQ
Bellerophon Therapeutics, Inc.
1W: +20.0%
1M: -68.4%
3M: -65.7%
1Y: -62.9%
3Y: -99.5%
5Y: -99.8%
$0.01
Last traded 2024-12-18 — delisted
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
📊 Key Metrics
TTM$6M
Revenue
+0.0% YoY
$-12M
Net Income
+38.9% YoY
$-12M
Free Cash Flow
+29.1% YoY
0.0%
Gross Margin
0.0%
Op. Margin
0.0%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
⚠️ Cash Burn Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-209.3%
ROA-132.7%
ROIC1322.9%
Valuation
P/E-0.0
P/B0.0
EV/EBITDA-0.0
Leverage
Debt/Equity0.00
Current Ratio3.96
Interest Cov.-125.4x
Quality Scores
Piotroski F4/9
Altman Z-75.03
Beneish M0.00